WASHINGTON (AP) — WASHINGTON (AP) — Vanda Pharmaceuticals Inc. (VNDA) on Wednesday reported a loss of $141.2 million in its fourth quarter.
The Washington-based company said it had a loss of $2.39 per share. Losses, adjusted for non-recurring costs, came to 46 cents per share.
The biopharmaceutical company posted revenue of $57.2 million in the period.
For the year, the company reported a loss of $220.5 million, or $3.74 per share. Revenue was reported as $216.1 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on VNDA at https://www.zacks.com/ap/VNDA
/AI%20(artificial%20intelligence)/AI%20microchip%20by%20DesignKingBD360%20via%20Shutterstock.jpg)
/2d%20illustration%20of%20Cloud%20computing%20by%20Blackboard%20via%20Shutterstock.jpg)
/Nvidia%20logo%20and%20sign%20on%20headquarters%20by%20Michael%20Vi%20via%20Shutterstock.jpg)
